المؤلفون: Gilles Vassal, John M. Maris, Fred Zheng, Elizabeth Fox, Athanasios C. Tsiatis, Joe McDonough, Donna Ludwinski, Julia Glade Bender, Vickie Buenger, Pratiti Bandopadhayay, Steven G. DuBois, Katarina Luptakova, Francis J. Giles, Patrick A. Brown, Mark W. Kieran, Andrew D.J. Pearson, Christopher A. French, Rajeev Vibhakar, Kelly Bennett, Kimberly Stegmaier, Joanna S. Yi, Franck Bourdeaut, Jessica Clymer, Maureen Hattersley, Susan L. Weiner, Zariana Nikolova, Malcolm A. Smith, Louis Chesler, Eva Germovsek

المصدر: European Journal of Cancer. 146:115-124

مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, Consensus, Antineoplastic Agents, Epigenesis, Genetic, 03 medical and health sciences, 0302 clinical medicine, Drug Development, Neoplasms, medicine, Humans, Molecular Targeted Therapy, Epigenetics, Child, Intensive care medicine, business.industry, Paediatric oncology, Proteins, Bromodomain, Clinical trial, 030104 developmental biology, Biopharmaceutical, Oncology, Drug development, 030220 oncology & carcinogenesis, New product development, business, Clinical evaluation

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f18e4d72597034f3fd35e30c663548ea
https://doi.org/10.1016/j.ejca.2021.01.018